miltefosine has been researched along with Mycoses in 9 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
Mycoses: Diseases caused by FUNGI.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Miltefosine is an alkylphosphocholine that shows broad-spectrum in vitro antifungal activities and limited in vivo efficacy in mouse models of cryptococcosis." | 3.79 | Synthesis and antifungal activities of miltefosine analogs. ( Agarwal, AK; Chen, YL; Clark, AM; Heitman, J; Jacob, MR; Khan, SI; Li, XC; Pan, X; Ravu, RR, 2013) |
| "Fungal infections are a global health problem with high mortality and morbidity rates." | 3.01 | Miltefosine repositioning: A review of potential alternative antifungal therapy. ( Borba-Santos, LP; Ishida, K; Rozental, S; Spadari, CC, 2023) |
| " This study determined the in vitro susceptibility of miltefosine, as a single agent and in combination with posaconazole or voriconazole, against these pathogens." | 1.39 | In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens. ( Biswas, C; Chen, SC; Djordjevic, JT; Jolliffe, KA; Sorrell, TC; Zuo, X, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Ravu, RR | 1 |
| Chen, YL | 1 |
| Jacob, MR | 1 |
| Pan, X | 1 |
| Agarwal, AK | 1 |
| Khan, SI | 1 |
| Heitman, J | 1 |
| Clark, AM | 1 |
| Li, XC | 1 |
| Wu, S | 1 |
| Wang, Y | 2 |
| Liu, N | 2 |
| Dong, G | 2 |
| Sheng, C | 2 |
| Tu, J | 1 |
| Spadari, CC | 1 |
| Borba-Santos, LP | 1 |
| Rozental, S | 1 |
| Ishida, K | 1 |
| Quaesaet, L | 1 |
| Stindel, E | 1 |
| Lanternier, F | 1 |
| Williams, T | 1 |
| Jaffuel, S | 1 |
| Moalic, E | 1 |
| Garcia Hermoso, D | 1 |
| Lortholary, O | 1 |
| Ansart, S | 1 |
| Biswas, C | 1 |
| Sorrell, TC | 2 |
| Djordjevic, JT | 1 |
| Zuo, X | 1 |
| Jolliffe, KA | 1 |
| Chen, SC | 1 |
| Compain, F | 1 |
| Botterel, F | 1 |
| Sitterlé, E | 1 |
| Paugam, A | 1 |
| Bougnoux, ME | 1 |
| Dannaoui, E | 1 |
| Kesson, AM | 1 |
| Bellemore, MC | 1 |
| O'Mara, TJ | 1 |
| Ellis, DH | 1 |
| Ferguson, LM | 1 |
| Dreisbach, AW | 1 |
| Csongrádi, E | 1 |
| Juncos, LA | 1 |
| Fulop, T | 1 |
3 reviews available for miltefosine and Mycoses
| Article | Year |
|---|---|
Tackling Fungal Resistance by Biofilm Inhibitors.
Topics: Animals; Antifungal Agents; Biofilms; Drug Discovery; Drug Resistance, Fungal; Fungi; Humans; Models | 2017 |
Emerging New Targets for the Treatment of Resistant Fungal Infections.
Topics: Antifungal Agents; Drug Resistance, Fungal; Humans; Molecular Targeted Therapy; Mycoses | 2018 |
Miltefosine repositioning: A review of potential alternative antifungal therapy.
Topics: Animals; Antifungal Agents; Drug Repositioning; Mycoses; Phosphorylcholine | 2023 |
6 other studies available for miltefosine and Mycoses
| Article | Year |
|---|---|
Synthesis and antifungal activities of miltefosine analogs.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida; Candidiasis; Cell Line; C | 2013 |
Miltefosine-based regimen as salvage therapy in Lomentospora prolificans bone and joint infection.
Topics: Aged; Antifungal Agents; Arthritis, Infectious; Humans; Male; Mycoses; Osteomyelitis; Phosphorylchol | 2018 |
In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens.
Topics: Antifungal Agents; Drug Synergism; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Phosphorylch | 2013 |
In vitro activity of miltefosine in combination with voriconazole or amphotericin B against clinical isolates of Scedosporium spp.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; M | 2015 |
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report.
Topics: Antifungal Agents; Child; Drug Therapy, Combination; Female; Fractures, Bone; Humans; Mycoses; Napht | 2009 |
Recurring extracorporeal circuit clotting during continuous renal replacement therapy in fungal sepsis: successful treatment with argatroban.
Topics: Antifungal Agents; Antithrombins; Arginine; Blood Coagulation; Coronary Artery Bypass; Humans; Male; | 2013 |